Top Story

Medical device firm Teleflex acquires MIT spinout for $30M

Medical device company Teleflex (NYSE:TFX) has acquired a biomedical company with an antimicrobial technology for devices in a $30 million deal. Semprus BioScience’s technology reduces the attachment of platelets and blood proteins at the surface of devices, according to a company statement. It closed an $18 million series B financing round in 2010 co-led by […]


Medical device company Teleflex’s epidural catheter gets FDA nod

An epidural catheter from medical device company Teleflex (NYSE:TFX) has received 51o(k) clearance from the U.S. Food and Drug Administration. The Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter is an expansion of the company’s Arrow FlexTip Plus catheter, according to a company statement. The FlexTip Plus design is aimed at significantly reducing complications commonly […]


Medical device company Teleflex replaces CFO

Teleflex (NYSE:TFX) has replaced its chief financial officer after a little more than two years with the company. Richard A. Meier’s employment was “terminated” March 9, according to a statement from the company. Thomas E. Powell will take over the role. Powell joined the company last year as the vice president for global finance. Powell […]